Abstract
Wnt signaling is critical for proper development of the embryo and for tissue homeostasis in the adult. Activation of this signaling cascade is initiated by binding of the secreted Wnts to their receptors. With the mammalian genome encoding multiple Wnts and Wnt receptors, a longstanding question in the field has been how Wnt-receptor specificities are achieved. Emerging from these studies is a picture of exquisite control over Wnt protein production, secretion, distribution, and receptor interactions, culminating in activation of downstream signaling cascades that control a myriad of biological processes. Here we discuss mechanisms by which Wnt protein activities are tuned and illustrate how the multiple layers of regulation can be leveraged for therapeutic interventions in disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Balemans W, Ebeling M, Patel N, Van Hul E, Olson P, Dioszegi M, Lacza C, Wuyts W, Van Den Ende J, Willems P, Paes-Alves AF, Hill S, Bueno M, Ramos FJ, Tacconi P, Dikkers FG, Stratakis C, Lindpaintner K, Vickery B, Foernzler D, Van Hul W (2001) Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 10:537–543. https://doi.org/10.1093/hmg/10.5.537
Bauer M, Benard J, Gaasterland T, Willert K, Cappellen D (2013) WNT5A encodes two isoforms with distinct functions in cancers. PLoS One 8:e80526. https://doi.org/10.1371/journal.pone.0080526
Berger C, Sommermeyer D, Hudecek M, Berger M, Balakrishnan A, Paszkiewicz PJ, Kosasih PL, Rader C, Riddell SR (2015) Safety of targeting ROR1 in primates with chimeric antigen receptor-modified T cells. Cancer Immunol Res 3:206–216. https://doi.org/10.1158/2326-6066.CIR-14-0163
Bhanot P, Fish M, Jemison JA, Nusse R, Nathans J, Cadigan KM (1999) Frizzled and Dfrizzled-2 function as redundant receptors for wingless during Drosophila embryonic development. Development 126:4175–4186
Biechele S, Cox BJ, Rossant J (2011) Porcupine homolog is required for canonical Wnt signaling and gastrulation in mouse embryos. Dev Biol 355:275–285. https://doi.org/10.1016/j.ydbio.2011.04.029
Brogi S, Maramai S, Brindisi M, Chemi G, Porcari V, Corallo C, Gennari L, Novellino E, Ramunno A, Butini S, Campiani G, Gemma S (2017) Activation of the Wnt pathway by small peptides: rational design, synthesis and biological evaluation. ChemMedChem 12:2074–2085. https://doi.org/10.1002/cmdc.201700551
Cancer Genome Atlas Network (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487:330–337. https://doi.org/10.1038/nature11252
Carmon KS, Gong X, Lin Q, Thomas A, Liu Q (2011) R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. Proc Natl Acad Sci U S A 108:11452–11457. https://doi.org/10.1073/pnas.1106083108
Chai G, Szenker-Ravi E, Chung C, Li Z, Wang L, Khatoo M, Marshall T, Jiang N, Yang X, McEvoy-Venneri J, Stanley V, Anzenberg P, Lang N, Wazny V, Yu J, Virshup DM, Nygaard R, Mancia F, Merdzanic R, Toralles MBP, Pitanga PML, Puri RD, Hernan R, Chung WK, Bertoli-Avella AM, Al-Sannaa N, Zaki MS, Willert K, Reversade B, Gleeson JG A human pleiotropic multiorgan condition caused by deficient Wnt secretion. N Engl J Med, in press
Chee YC, Pahnke J, Bunte R, Adsool VA, Madan B, Virshup DM (2018) Intrinsic xenobiotic resistance of the intestinal stem cell niche. Dev Cell 46:681–695.e5. https://doi.org/10.1016/j.devcel.2018.07.023
Chen B, Dodge ME, Tang W, Lu J, Ma Z, Fan CW, Wei S, Hao W, Kilgore J, Williams NS, Roth MG, Amatruda JF, Chen C, Lum L (2009) Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nat Chem Biol 5:100–107. https://doi.org/10.1038/nchembio.137
Chen H, Lu C, Ouyang B, Zhang H, Huang Z, Bhatia D, Lee SJ, Shah D, Sura A, Yeh WC, Li Y (2020) Development of potent, selective surrogate WNT molecules and their application in defining frizzled requirements. Cell Chem Biol 27:598–609.e4. https://doi.org/10.1016/j.chembiol.2020.02.009
Chidiac R, Abedin M, Macleod G, Yang A, Thibeault PE, Blazer LL, Adams JJ, Zhang L, Roehrich H, Jo HN, Seshagiri S, Sidhu SS, Junge HJ, Angers S (2021) A Norrin/Wnt surrogate antibody stimulates endothelial cell barrier function and rescues retinopathy. EMBO Mol Med:e13977. https://doi.org/10.15252/emmm.202113977
Ching W, Hang HC, Nusse R (2008) Lipid-independent secretion of a drosophila Wnt protein. J Biol Chem 283:17092–17098. https://doi.org/10.1074/jbc.M802059200
Cho C, Smallwood PM, Nathans J (2017) Reck and Gpr124 are essential receptor cofactors for Wnt7a/Wnt7b-specific signaling in mammalian CNS angiogenesis and blood-brain barrier regulation. Neuron 95:1056–1073.e5. https://doi.org/10.1016/j.neuron.2017.07.031
Cho C, Wang Y, Smallwood PM, Williams J, Nathans J (2019) Molecular determinants in Frizzled, Reck, and Wnt7a for ligand-specific signaling in neurovascular development. eLife 8. https://doi.org/10.7554/eLife.47300
Choi MY, Widhopf GF 2nd, Ghia EM, Kidwell RL, Hasan MK, Yu J, Rassenti LZ, Chen L, Chen Y, Pittman E, Pu M, Messer K, Prussak CE, Castro JE, Jamieson C, Kipps TJ (2018) Phase I trial: cirmtuzumab inhibits ROR1 signaling and stemness signatures in patients with chronic lymphocytic leukemia. Cell Stem Cell 22:951–959.e3. https://doi.org/10.1016/j.stem.2018.05.018
Chu ML, Ahn VE, Choi HJ, Daniels DL, Nusse R, Weis WI (2013) Structural studies of Wnts and identification of an LRP6 binding site. Structure 21:1235–1242. https://doi.org/10.1016/j.str.2013.05.006
Coyac BR, Leahy B, Li Z, Salvi G, Yin X, Brunski JB, Helms JA (2020) Bone formation around unstable implants is enhanced by a WNT protein therapeutic in a preclinical in vivo model. Clin Oral Implants Res 31:1125–1137. https://doi.org/10.1111/clr.13659
Damelin M, Bankovich A, Bernstein J, Lucas J, Chen L, Williams S, Park A, Aguilar J, Ernstoff E, Charati M, Dushin R, Aujay M, Lee C, Ramoth H, Milton M, Hampl J, Lazetic S, Pulito V, Rosfjord E, Sun Y, King L, Barletta F, Betts A, Guffroy M, Falahatpisheh H, O'Donnell CJ, Stull R, Pysz M, Escarpe P, Liu D, Foord O, Gerber HP, Sapra P, Dylla SJ (2017) A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions. Sci Transl Med 9. https://doi.org/10.1126/scitranslmed.aag2611
D’Amico L, Mahajan S, Capietto AH, Yang Z, Zamani A, Ricci B, Bumpass DB, Meyer M, Su X, Wang-Gillam A, Weilbaecher K, Stewart SA, DeNardo DG, Faccio R (2016) Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer. J Exp Med 213:827–840. https://doi.org/10.1084/jem.20150950
Dang LT, Miao Y, Ha A, Yuki K, Park K, Janda CY, Jude KM, Mohan K, Ha N, Vallon M, Yuan J, Vilches-Moure JG, Kuo CJ, Garcia KC, Baker D (2019) Receptor subtype discrimination using extensive shape complementary designed interfaces. Nat Struct Mol Biol 26:407–414. https://doi.org/10.1038/s41594-019-0224-z
de Lau W, Barker N, Low TY, Koo BK, Li VS, Teunissen H, Kujala P, Haegebarth A, Peters PJ, van de Wetering M, Stange DE, van Es JE, Guardavaccaro D, Schasfoort RB, Mohri Y, Nishimori K, Mohammed S, Heck AJ, Clevers H (2011) Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 476:293–297. https://doi.org/10.1038/nature10337
DeBruine ZJ, Ke J, Harikumar KG, Gu X, Borowsky P, Williams BO, Xu W, Miller LJ, Xu HE, Melcher K (2017a) Wnt5a promotes Frizzled-4 signalosome assembly by stabilizing cysteine-rich domain dimerization. Genes Dev 31:916–926. https://doi.org/10.1101/gad.298331.117
DeBruine ZJ, Xu HE, Melcher K (2017b) Assembly and architecture of the Wnt/beta-catenin signalosome at the membrane. Br J Pharmacol 174:4564–4574. https://doi.org/10.1111/bph.14048
Dijksterhuis JP, Baljinnyam B, Stanger K, Sercan HO, Ji Y, Andres O, Rubin JS, Hannoush RN, Schulte G (2015) Systematic mapping of WNT-FZD protein interactions reveals functional selectivity by distinct WNT-FZD pairs. J Biol Chem 290:6789–6798. https://doi.org/10.1074/jbc.M114.612648
Eubelen M, Bostaille N, Cabochette P, Gauquier A, Tebabi P, Dumitru AC, Koehler M, Gut P, Alsteens D, Stainier DYR, Garcia-Pino A, Vanhollebeke B (2018) A molecular mechanism for Wnt ligand-specific signaling. Science 361. https://doi.org/10.1126/science.aat1178
Fischer MM, Cancilla B, Yeung VP, Cattaruzza F, Chartier C, Murriel CL, Cain J, Tam R, Cheng CY, Evans JW, O'Young G, Song X, Lewicki J, Kapoun AM, Gurney A, Yen WC, Hoey T (2017) WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death. Sci Adv 3:e1700090. https://doi.org/10.1126/sciadv.1700090
Florio M, Gunasekaran K, Stolina M, Li X, Liu L, Tipton B, Salimi-Moosavi H, Asuncion FJ, Li C, Sun B, Tan HL, Zhang L, Han CY, Case R, Duguay AN, Grisanti M, Stevens J, Pretorius JK, Pacheco E, Jones H, Chen Q, Soriano BD, Wen J, Heron B, Jacobsen FW, Brisan E, Richards WG, Ke HZ, Ominsky MS (2016) A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair. Nat Commun 7:11505. https://doi.org/10.1038/ncomms11505
Fukuda T, Chen L, Endo T, Tang L, Lu D, Castro JE, Widhopf GF 2nd, Rassenti LZ, Cantwell MJ, Prussak CE, Carson DA, Kipps TJ (2008) Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a. Proc Natl Acad Sci U S A 105:3047–3052. https://doi.org/10.1073/pnas.0712148105
Fukukawa C, Hanaoka H, Nagayama S, Tsunoda T, Toguchida J, Endo K, Nakamura Y, Katagiri T (2008) Radioimmunotherapy of human synovial sarcoma using a monoclonal antibody against FZD10. Cancer Sci 99:432–440. https://doi.org/10.1111/j.1349-7006.2007.00701.x
Funck-Brentano T, Nilsson KH, Brommage R, Henning P, Lerner UH, Koskela A, Tuukkanen J, Cohen-Solal M, Moverare-Skrtic S, Ohlsson C (2018) Porcupine inhibitors impair trabecular and cortical bone mass and strength in mice. J Endocrinol 238:13–23. https://doi.org/10.1530/JOE-18-0153
Goldstein SD, Trucco M, Bautista Guzman W, Hayashi M, Loeb DM (2016) A monoclonal antibody against the Wnt signaling inhibitor dickkopf-1 inhibits osteosarcoma metastasis in a preclinical model. Oncotarget 7:21114–21123. https://doi.org/10.18632/oncotarget.8522
Grainger S, Richter J, Palazon RE, Pouget C, Lonquich B, Wirth S, Grassme KS, Herzog W, Swift MR, Weinstein BM, Traver D, Willert K (2016) Wnt9a is required for the aortic amplification of nascent hematopoietic stem cells. Cell Rep 17:1595–1606. https://doi.org/10.1016/j.celrep.2016.10.027
Grainger S, Nguyen N, Richter J, Setayesh J, Lonquich B, Oon CH, Wozniak JM, Barahona R, Kamei CN, Houston J, Carrillo-Terrazas M, Drummond IA, Gonzalez D, Willert K, Traver D (2019) EGFR is required for Wnt9a-Fzd9b signalling specificity in haematopoietic stem cells. Nat Cell Biol 21:721–730. https://doi.org/10.1038/s41556-019-0330-5
Greicius G, Kabiri Z, Sigmundsson K, Liang C, Bunte R, Singh MK, Virshup DM (2018) PDGFRalpha(+) pericryptal stromal cells are the critical source of Wnts and RSPO3 for murine intestinal stem cells in vivo. Proc Natl Acad Sci U S A 115:E3173–E3181. https://doi.org/10.1073/pnas.1713510115
Gross JC, Chaudhary V, Bartscherer K, Boutros M (2012) Active Wnt proteins are secreted on exosomes. Nat Cell Biol 14:1036–1045. https://doi.org/10.1038/ncb2574
Grzeschik KH, Bornholdt D, Oeffner F, Konig A, del Carmen BM, Enders H, Fritz B, Hertl M, Grasshoff U, Hofling K, Oji V, Paradisi M, Schuchardt C, Szalai Z, Tadini G, Traupe H, Happle R (2007) Deficiency of PORCN, a regulator of Wnt signaling, is associated with focal dermal hypoplasia. Nat Genet 39:833–835. https://doi.org/10.1038/ng2052
Gumber D, Do M, Suresh Kumar N, Sonavane PR, Wu CCN, Cruz LS, Grainger S, Carson D, Gaasterland T, Willert K (2020) Selective activation of FZD7 promotes mesendodermal differentiation of human pluripotent stem cells. eLife 9. https://doi.org/10.7554/eLife.63060
Gurney A, Axelrod F, Bond CJ, Cain J, Chartier C, Donigan L, Fischer M, Chaudhari A, Ji M, Kapoun AM, Lam A, Lazetic S, Ma S, Mitra S, Park IK, Pickell K, Sato A, Satyal S, Stroud M, Tran H, Yen WC, Lewicki J, Hoey T (2012) Wnt pathway inhibition via the targeting of frizzled receptors results in decreased growth and tumorigenicity of human tumors. Proc Natl Acad Sci U S A 109:11717–11722. https://doi.org/10.1073/pnas.1120068109
Hanaki H, Yamamoto H, Sakane H, Matsumoto S, Ohdan H, Sato A, Kikuchi A (2012) An anti-Wnt5a antibody suppresses metastasis of gastric cancer cells in vivo by inhibiting receptor-mediated endocytosis. Mol Cancer Ther 11:298–307. https://doi.org/10.1158/1535-7163.MCT-11-0682
Hansen S, Nile AH, Mehta SC, Fuhrmann J, Hannoush RN (2019) Lead optimization yields high affinity frizzled 7-targeting peptides that modulate Clostridium difficile toxin B pathogenicity in epithelial cells. J Med Chem 62:7739–7750. https://doi.org/10.1021/acs.jmedchem.9b00500
He X, Saint-Jeannet JP, Wang Y, Nathans J, Dawid I, Varmus H (1997) A member of the frizzled protein family mediating axis induction by Wnt-5A. Science 275:1652–1654. https://doi.org/10.1126/science.275.5306.1652
He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW (1998) Identification of c-MYC as a target of the APC pathway. Science 281:1509–1512. https://doi.org/10.1126/science.281.5382.1509
He B, You L, Uematsu K, Xu Z, Lee AY, Matsangou M, McCormick F, Jablons DM (2004) A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia 6:7–14. https://doi.org/10.1016/s1476-5586(04)80048-4
Herr P, Basler K (2012) Porcupine-mediated lipidation is required for Wnt recognition by Wls. Dev Biol 361:392–402. https://doi.org/10.1016/j.ydbio.2011.11.003
Hirai H, Matoba K, Mihara E, Arimori T, Takagi J (2019) Crystal structure of a mammalian Wnt-frizzled complex. Nat Struct Mol Biol 26:372–379. https://doi.org/10.1038/s41594-019-0216-z
Ho HY, Susman MW, Bikoff JB, Ryu YK, Jonas AM, Hu L, Kuruvilla R, Greenberg ME (2012) Wnt5a-Ror-Dishevelled signaling constitutes a core developmental pathway that controls tissue morphogenesis. Proc Natl Acad Sci U S A 109:4044–4051. https://doi.org/10.1073/pnas.1200421109
Hofmann K (2000) A superfamily of membrane-bound O-acyltransferases with implications for wnt signaling. Trends Biochem Sci 25:111–112. https://doi.org/10.1016/s0968-0004(99)01539-x
Hsiung F, Ramirez-Weber FA, Iwaki DD, Kornberg TB (2005) Dependence of drosophila wing imaginal disc cytonemes on decapentaplegic. Nature 437:560–563. https://doi.org/10.1038/nature03951
Huang TC, Lee PT, Wu MH, Huang CC, Ko CY, Lee YC, Lin DY, Cheng YW, Lee KH (2017) Distinct roles and differential expression levels of Wnt5a mRNA isoforms in colorectal cancer cells. PLoS One 12:e0181034. https://doi.org/10.1371/journal.pone.0181034
Huggins IJ, Bos T, Gaylord O, Jessen C, Lonquich B, Puranen A, Richter J, Rossdam C, Brafman D, Gaasterland T, Willert K (2017) The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells. Nat Commun 8:1034. https://doi.org/10.1038/s41467-017-01203-1
Iyer SP, Beck JT, Stewart AK, Shah J, Kelly KR, Isaacs R, Bilic S, Sen S, Munshi NC (2014) A phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events. Br J Haematol 167:366–375. https://doi.org/10.1111/bjh.13056
Janda CY, Waghray D, Levin AM, Thomas C, Garcia KC (2012) Structural basis of Wnt recognition by frizzled. Science 337:59–64. https://doi.org/10.1126/science.1222879
Janda CY, Dang LT, You C, Chang J, de Lau W, Zhong ZA, Yan KS, Marecic O, Siepe D, Li X, Moody JD, Williams BO, Clevers H, Piehler J, Baker D, Kuo CJ, Garcia KC (2017) Surrogate Wnt agonists that phenocopy canonical Wnt and beta-catenin signalling. Nature 545:234–237. https://doi.org/10.1038/nature22306
Jenei V, Sherwood V, Howlin J, Linnskog R, Safholm A, Axelsson L, Andersson T (2009) A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion. Proc Natl Acad Sci U S A 106:19473–19478. https://doi.org/10.1073/pnas.0909409106
Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F (2002) Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22:1172–1183. https://doi.org/10.1128/mcb.22.4.1172-1183.2002
Jiang X, Hao HX, Growney JD, Woolfenden S, Bottiglio C, Ng N, Lu B, Hsieh MH, Bagdasarian L, Meyer R, Smith TR, Avello M, Charlat O, Xie Y, Porter JA, Pan S, Liu J, McLaughlin ME, Cong F (2013) Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma. Proc Natl Acad Sci U S A 110:12649–12654. https://doi.org/10.1073/pnas.1307218110
Jiang J, Lan C, Li L, Yang D, Xia X, Liao Q, Fu W, Chen X, An S, Wang WE, Zeng C (2018) A novel porcupine inhibitor blocks WNT pathways and attenuates cardiac hypertrophy. Biochim Biophys Acta Mol basis Dis 1864:3459–3467. https://doi.org/10.1016/j.bbadis.2018.07.035
Kadowaki T, Wilder E, Klingensmith J, Zachary K, Perrimon N (1996) The segment polarity gene porcupine encodes a putative multitransmembrane protein involved in wingless processing. Genes Dev 10:3116–3128. https://doi.org/10.1101/gad.10.24.3116
Kaiser K, Gyllborg D, Prochazka J, Salasova A, Kompanikova P, Molina FL, Laguna-Goya R, Radaszkiewicz T, Harnos J, Prochazkova M, Potesil D, Barker RA, Casado AG, Zdrahal Z, Sedlacek R, Arenas E, Villaescusa JC, Bryja V (2019) WNT5A is transported via lipoprotein particles in the cerebrospinal fluid to regulate hindbrain morphogenesis. Nat Commun 10:1498. https://doi.org/10.1038/s41467-019-09298-4
Kakugawa S, Langton PF, Zebisch M, Howell S, Chang TH, Liu Y, Feizi T, Bineva G, O'Reilly N, Snijders AP, Jones EY, Vincent JP (2015) Notum deacylates Wnt proteins to suppress signalling activity. Nature 519:187–192. https://doi.org/10.1038/nature14259
Kaykas A, Yang-Snyder J, Heroux M, Shah KV, Bouvier M, Moon RT (2004) Mutant frizzled 4 associated with vitreoretinopathy traps wild-type Frizzled in the endoplasmic reticulum by oligomerization. Nat Cell Biol 6:52–58. https://doi.org/10.1038/ncb1081
Kim GH, Her JH, Han JK (2008a) Ryk cooperates with Frizzled 7 to promote Wnt11-mediated endocytosis and is essential for Xenopus laevis convergent extension movements. J Cell Biol 182:1073–1082. https://doi.org/10.1083/jcb.200710188
Kim KA, Wagle M, Tran K, Zhan X, Dixon MA, Liu S, Gros D, Korver W, Yonkovich S, Tomasevic N, Binnerts M, Abo A (2008b) R-Spondin family members regulate the Wnt pathway by a common mechanism. Mol Biol Cell 19:2588–2596. https://doi.org/10.1091/mbc.E08-02-0187
Koo BK, van Es JH, van den Born M, Clevers H (2015) Porcupine inhibitor suppresses paracrine Wnt-driven growth of Rnf43;Znrf3-mutant neoplasia. Proc Natl Acad Sci U S A 112:7548–7550. https://doi.org/10.1073/pnas.1508113112
Korkut C, Ataman B, Ramachandran P, Ashley J, Barria R, Gherbesi N, Budnik V (2009) Trans-synaptic transmission of vesicular Wnt signals through Evi/Wntless. Cell 139:393–404. https://doi.org/10.1016/j.cell.2009.07.051
Li X, Zhang Y, Kang H, Liu W, Liu P, Zhang J, Harris SE, Wu D (2005) Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem 280:19883–19887. https://doi.org/10.1074/jbc.M413274200
Li Z, Yuan X, Arioka M, Bahat D, Sun Q, Chen J, Helms JA (2021) Pro-osteogenic effects of WNT in a mouse model of bone formation around femoral implants. Calcif Tissue Int 108:240–251. https://doi.org/10.1007/s00223-020-00757-5
Liang H, Chen Q, Coles AH, Anderson SJ, Pihan G, Bradley A, Gerstein R, Jurecic R, Jones SN (2003) Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell 4:349–360. https://doi.org/10.1016/s1535-6108(03)00268-x
Liu J, Pan S, Hsieh MH, Ng N, Sun F, Wang T, Kasibhatla S, Schuller AG, Li AG, Cheng D, Li J, Tompkins C, Pferdekamper A, Steffy A, Cheng J, Kowal C, Phung V, Guo G, Wang Y, Graham MP, Flynn S, Brenner JC, Li C, Villarroel MC, Schultz PG, Wu X, McNamara P, Sellers WR, Petruzzelli L, Boral AL, Seidel HM, McLaughlin ME, Che J, Carey TE, Vanasse G, Harris JL (2013) Targeting Wnt-driven cancer through the inhibition of porcupine by LGK974. Proc Natl Acad Sci U S A 110:20224–20229. https://doi.org/10.1073/pnas.1314239110
Luga V, Zhang L, Viloria-Petit AM, Ogunjimi AA, Inanlou MR, Chiu E, Buchanan M, Hosein AN, Basik M, Wrana JL (2012) Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 151:1542–1556. https://doi.org/10.1016/j.cell.2012.11.024
Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T, Karsten U, van de Wetering M, Clevers H, Schlag PM, Birchmeier W, Behrens J (2002) Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol 22:1184–1193. https://doi.org/10.1128/mcb.22.4.1184-1193.2002
Madan B, Ke Z, Harmston N, Ho SY, Frois AO, Alam J, Jeyaraj DA, Pendharkar V, Ghosh K, Virshup IH, Manoharan V, Ong EH, Sangthongpitag K, Hill J, Petretto E, Keller TH, Lee MA, Matter A, Virshup DM (2016) Wnt addiction of genetically defined cancers reversed by PORCN inhibition. Oncogene 35:2197–2207. https://doi.org/10.1038/onc.2015.280
Madan B, McDonald MJ, Foxa GE, Diegel CR, Williams BO, Virshup DM (2018) Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy. Bone Res 6:17. https://doi.org/10.1038/s41413-018-0017-8
Malladi S, Macalinao DG, Jin X, He L, Basnet H, Zou Y, de Stanchina E, Massague J (2016) Metastatic latency and immune evasion through autocrine inhibition of WNT. Cell 165:45–60. https://doi.org/10.1016/j.cell.2016.02.025
Mao B, Wu W, Li Y, Hoppe D, Stannek P, Glinka A, Niehrs C (2001) LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411:321–325. https://doi.org/10.1038/35077108
McGough IJ, Vecchia L, Bishop B, Malinauskas T, Beckett K, Joshi D, O'Reilly N, Siebold C, Jones EY, Vincent JP (2020) Glypicans shield the Wnt lipid moiety to enable signalling at a distance. Nature 585:85–90. https://doi.org/10.1038/s41586-020-2498-z
Miao Y, Ha A, de Lau W, Yuki K, Santos AJM, You C, Geurts MH, Puschhof J, Pleguezuelos-Manzano C, Peng WC, Senlice R, Piani C, Buikema JW, Gbenedio OM, Vallon M, Yuan J, de Haan S, Hemrika W, Rosch K, Dang LT, Baker D, Ott M, Depeille P, Wu SM, Drost J, Nusse R, Roose JP, Piehler J, Boj SF, Janda CY, Clevers H, Kuo CJ, Garcia KC (2020) Next-generation surrogate Wnts support organoid growth and deconvolute frizzled pleiotropy in vivo. Cell Stem Cell. https://doi.org/10.1016/j.stem.2020.07.020
Mihara E, Hirai H, Yamamoto H, Tamura-Kawakami K, Matano M, Kikuchi A, Sato T, Takagi J (2016) Active and water-soluble form of lipidated Wnt protein is maintained by a serum glycoprotein afamin/alpha-albumin. eLife:5. https://doi.org/10.7554/eLife.11621
Mikels AJ, Nusse R (2006) Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 4:e115. https://doi.org/10.1371/journal.pbio.0040115
Minear S, Leucht P, Jiang J, Liu B, Zeng A, Fuerer C, Nusse R, Helms JA (2010) Wnt proteins promote bone regeneration. Sci Transl Med 2:29ra30. https://doi.org/10.1126/scitranslmed.3000231
Moore KN, Gunderson CC, Sabbatini P, McMeekin DS, Mantia-Smaldone G, Burger RA, Morgan MA, Kapoun AM, Brachmann RK, Stagg R, Farooki A, O'Cearbhaill RE (2019) A phase 1b dose escalation study of ipafricept (OMP54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer. Gynecol Oncol 154:294–301. https://doi.org/10.1016/j.ygyno.2019.04.001
Morrell NT, Leucht P, Zhao L, Kim JB, ten Berge D, Ponnusamy K, Carre AL, Dudek H, Zachlederova M, McElhaney M, Brunton S, Gunzner J, Callow M, Polakis P, Costa M, Zhang XM, Helms JA, Nusse R (2008) Liposomal packaging generates Wnt protein with in vivo biological activity. PLoS One 3:e2930. https://doi.org/10.1371/journal.pone.0002930
Motono M, Ioroi Y, Ogura T, Takahashi J (2016) WNT-C59, a small-molecule WNT inhibitor, efficiently induces anterior cortex that includes cortical motor neurons from human pluripotent stem cells. Stem Cells Transl Med 5:552–560. https://doi.org/10.5966/sctm.2015-0261
Mulligan KA, Fuerer C, Ching W, Fish M, Willert K, Nusse R (2012) Secreted wingless-interacting molecule (Swim) promotes long-range signaling by maintaining wingless solubility. Proc Natl Acad Sci U S A 109:370–377. https://doi.org/10.1073/pnas.1119197109
Neumann S, Coudreuse DY, van der Westhuyzen DR, Eckhardt ER, Korswagen HC, Schmitz G, Sprong H (2009) Mammalian Wnt3a is released on lipoprotein particles. Traffic 10:334–343. https://doi.org/10.1111/j.1600-0854.2008.00872.x
Nile AH, Mukund S, Stanger K, Wang W, Hannoush RN (2017) Unsaturated fatty acyl recognition by frizzled receptors mediates dimerization upon Wnt ligand binding. Proc Natl Acad Sci U S A 114:4147–4152. https://doi.org/10.1073/pnas.1618293114
Nishita M, Itsukushima S, Nomachi A, Endo M, Wang Z, Inaba D, Qiao S, Takada S, Kikuchi A, Minami Y (2010) Ror2/Frizzled complex mediates Wnt5a-induced AP-1 activation by regulating Dishevelled polymerization. Mol Cell Biol 30:3610–3619. https://doi.org/10.1128/MCB.00177-10
Nomi M, Oishi I, Kani S, Suzuki H, Matsuda T, Yoda A, Kitamura M, Itoh K, Takeuchi S, Takeda K, Akira S, Ikeya M, Takada S, Minami Y (2001) Loss of mRor1 enhances the heart and skeletal abnormalities in mRor2-deficient mice: redundant and pleiotropic functions of mRor1 and mRor2 receptor tyrosine kinases. Mol Cell Biol 21:8329–8335. https://doi.org/10.1128/MCB.21.24.8329-8335.2001
Nusse R, Varmus HE (1982) Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31:99–109. https://doi.org/10.1016/0092-8674(82)90409-3
Nygaard R, Yu J, Kim J, Ross DR, Parisi G, Clarke OB, Virshup DM, Mancia F (2021) Structural basis of WLS/Evi-mediated Wnt transport and secretion. Cell 184:194–206.e14. https://doi.org/10.1016/j.cell.2020.11.038
Ominsky MS, Boyce RW, Li X, Ke HZ (2017) Effects of sclerostin antibodies in animal models of osteoporosis. Bone 96:63–75. https://doi.org/10.1016/j.bone.2016.10.019
Otero-Ramirez ME, Matoba K, Mihara E, Passioura T, Takagi J, Suga H (2020) Macrocyclic peptides that inhibit Wnt signalling via interaction with Wnt3a. RSC Chem Biol 1:26–34. https://doi.org/10.1039/d0cb00016g
Panakova D, Sprong H, Marois E, Thiele C, Eaton S (2005) Lipoprotein particles are required for hedgehog and wingless signalling. Nature 435:58–65. https://doi.org/10.1038/nature03504
Peradziryi H, Kaplan NA, Podleschny M, Liu X, Wehner P, Borchers A, Tolwinski NS (2011) PTK7/Otk interacts with Wnts and inhibits canonical Wnt signalling. EMBO J 30:3729–3740. https://doi.org/10.1038/emboj.2011.236
Petersen J, Wright SC, Rodriguez D, Matricon P, Lahav N, Vromen A, Friedler A, Stromqvist J, Wennmalm S, Carlsson J, Schulte G (2017) Agonist-induced dimer dissociation as a macromolecular step in G protein-coupled receptor signaling. Nat Commun 8:226. https://doi.org/10.1038/s41467-017-00253-9
Posokhova E, Shukla A, Seaman S, Volate S, Hilton MB, Wu B, Morris H, Swing DA, Zhou M, Zudaire E, Rubin JS, St Croix B (2015) GPR124 functions as a WNT7-specific coactivator of canonical beta-catenin signaling. Cell Rep 10:123–130. https://doi.org/10.1016/j.celrep.2014.12.020
Proffitt KD, Madan B, Ke Z, Pendharkar V, Ding L, Lee MA, Hannoush RN, Virshup DM (2013) Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer. Cancer Res 73:502–507. https://doi.org/10.1158/0008-5472.CAN-12-2258
Rhee CS, Sen M, Lu D, Wu C, Leoni L, Rubin J, Corr M, Carson DA (2002) Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene 21:6598–6605. https://doi.org/10.1038/sj.onc.1205920
Rulifson EJ, Wu CH, Nusse R (2000) Pathway specificity by the bifunctional receptor frizzled is determined by affinity for wingless. Mol Cell 6:117–126
Säfholm A, Leandersson K, Dejmek J, Nielsen CK, Villoutreix BO, Andersson T (2006) A formylated hexapeptide ligand mimics the ability of Wnt-5a to impair migration of human breast epithelial cells. J Biol Chem 281:2740–2749. https://doi.org/10.1074/jbc.M508386200
Salik B, Yi H, Hassan N, Santiappillai N, Vick B, Connerty P, Duly A, Trahair T, Woo AJ, Beck D, Liu T, Spiekermann K, Jeremias I, Wang J, Kavallaris M, Haber M, Norris MD, Liebermann DA, D’Andrea RJ, Murriel C, Wang JY (2020) Targeting RSPO3-LGR4 signaling for leukemia stem cell eradication in acute myeloid leukemia. Cancer Cell 38:263–278.e6. https://doi.org/10.1016/j.ccell.2020.05.014
Seo J, Kee HJ, Choi HJ, Lee JE, Park SY, Lee SH, Jeong MH, Guk G, Lee S, Choi KC, Choi YY, Kim H, Noh SH, Yoon HG, Cheong JH (2018) Inhibition of Wntless/GPR177 suppresses gastric tumorigenesis. BMB Rep 51:255–260. https://doi.org/10.5483/bmbrep.2018.51.5.046
Seshagiri S, Stawiski EW, Durinck S, Modrusan Z, Storm EE, Conboy CB, Chaudhuri S, Guan Y, Janakiraman V, Jaiswal BS, Guillory J, Ha C, Dijkgraaf GJ, Stinson J, Gnad F, Huntley MA, Degenhardt JD, Haverty PM, Bourgon R, Wang W, Koeppen H, Gentleman R, Starr TK, Zhang Z, Largaespada DA, Wu TD, de Sauvage FJ (2012) Recurrent R-spondin fusions in colon cancer. Nature 488:660–664. https://doi.org/10.1038/nature11282
Sheetz JB, Mathea S, Karvonen H, Malhotra K, Chatterjee D, Niininen W, Perttila R, Preuss F, Suresh K, Stayrook SE, Tsutsui Y, Radhakrishnan R, Ungureanu D, Knapp S, Lemmon MA (2020) Structural insights into pseudokinase domains of receptor tyrosine kinases. Mol Cell 79:390–405.e7. https://doi.org/10.1016/j.molcel.2020.06.018
Shinno N, Kimura H, Sada R, Takiguchi S, Mori M, Fumoto K, Doki Y, Kikuchi A (2018) Activation of the Dickkopf1-CKAP4 pathway is associated with poor prognosis of esophageal cancer and anti-CKAP4 antibody may be a new therapeutic drug. Oncogene 37:3471–3484. https://doi.org/10.1038/s41388-018-0179-2
Stanganello E, Hagemann AI, Mattes B, Sinner C, Meyen D, Weber S, Schug A, Raz E, Scholpp S (2015) Filopodia-based Wnt transport during vertebrate tissue patterning. Nat Commun 6:5846. https://doi.org/10.1038/ncomms6846
Susman MW, Karuna EP, Kunz RC, Gujral TS, Cantu AV, Choi SS, Jong BY, Okada K, Scales MK, Hum J, Hu LS, Kirschner MW, Nishinakamura R, Yamada S, Laird DJ, Jao LE, Gygi SP, Greenberg ME, Ho HH (2017) Kinesin superfamily protein Kif26b links Wnt5a-Ror signaling to the control of cell and tissue behaviors in vertebrates. eLife 6. https://doi.org/10.7554/eLife.26509
Szenker-Ravi E, Altunoglu U, Leushacke M, Bosso-Lefevre C, Khatoo M, Thi Tran H, Naert T, Noelanders R, Hajamohideen A, Beneteau C, de Sousa SB, Karaman B, Latypova X, Basaran S, Yucel EB, Tan TT, Vlaminck L, Nayak SS, Shukla A, Girisha KM, Le Caignec C, Soshnikova N, Uyguner ZO, Vleminckx K, Barker N, Kayserili H, Reversade B (2018) RSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently of LGR4/5/6. Nature 557:564–569. https://doi.org/10.1038/s41586-018-0118-y
Takada R, Satomi Y, Kurata T, Ueno N, Norioka S, Kondoh H, Takao T, Takada S (2006) Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion. Dev Cell 11:791–801. https://doi.org/10.1016/j.devcel.2006.10.003
Tammela T, Sanchez-Rivera FJ, Cetinbas NM, Wu K, Joshi NS, Helenius K, Park Y, Azimi R, Kerper NR, Wesselhoeft RA, Gu X, Schmidt L, Cornwall-Brady M, Yilmaz OH, Xue W, Katajisto P, Bhutkar A, Jacks T (2017) A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma. Nature 545:355–359. https://doi.org/10.1038/nature22334
Tao Y, Mis M, Blazer L, Ustav MJ, Steinhart Z, Chidiac R, Kubarakos E, O'Brien S, Wang X, Jarvik N, Patel N, Adams J, Moffat J, Angers S, Sidhu SS (2019) Tailored tetravalent antibodies potently and specifically activate Wnt/Frizzled pathways in cells, organoids and mice. eLife 8. https://doi.org/10.7554/eLife.46134
Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE (1988) Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55:619–625. https://doi.org/10.1016/0092-8674(88)90220-6
Tuysuz N, van Bloois L, van den Brink S, Begthel H, Verstegen MM, Cruz LJ, Hui L, van der Laan LJ, de Jonge J, Vries R, Braakman E, Mastrobattista E, Cornelissen JJ, Clevers H, Ten Berge D (2017) Lipid-mediated Wnt protein stabilization enables serum-free culture of human organ stem cells. Nat Commun 8:14578. https://doi.org/10.1038/ncomms14578
Ulrich F, Carretero-Ortega J, Menendez J, Narvaez C, Sun B, Lancaster E, Pershad V, Trzaska S, Veliz E, Kamei M, Prendergast A, Kidd KR, Shaw KM, Castranova DA, Pham VN, Lo BD, Martin BL, Raible DW, Weinstein BM, Torres-Vazquez J (2016) Reck enables cerebrovascular development by promoting canonical Wnt signaling. Development 143:147–159. https://doi.org/10.1242/dev.123059
Vaisitti T, Arruga F, Vitale N, Lee TT, Ko M, Chadburn A, Braggio E, Di Napoli A, Iannello A, Allan J, Miller LL, Lannutti BJ, Furman RR, Jessen K, Deaglio S (2021) ROR1 targeting with the antibody drug-conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse models. Blood. https://doi.org/10.1182/blood.2020008404
Vallon M, Yuki K, Nguyen TD, Chang J, Yuan J, Siepe D, Miao Y, Essler M, Noda M, Garcia KC, Kuo CJ (2018) A RECK-WNT7 receptor-ligand interaction enables isoform-specific regulation of Wnt bioavailability. Cell Rep 25:339–349.e9. https://doi.org/10.1016/j.celrep.2018.09.045
van Amerongen R, Bowman AN, Nusse R (2012a) Developmental stage and time dictate the fate of Wnt/beta-catenin-responsive stem cells in the mammary gland. Cell Stem Cell 11:387–400. https://doi.org/10.1016/j.stem.2012.05.023
van Amerongen R, Fuerer C, Mizutani M, Nusse R (2012b) Wnt5a can both activate and repress Wnt/beta-catenin signaling during mouse embryonic development. Dev Biol 369:101–114. https://doi.org/10.1016/j.ydbio.2012.06.020
van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, Pronk A, van Houdt W, van Gorp J, Taylor-Weiner A, Kester L, McLaren-Douglas A, Blokker J, Jaksani S, Bartfeld S, Volckman R, van Sluis P, Li VS, Seepo S, Sekhar Pedamallu C, Cibulskis K, Carter SL, McKenna A, Lawrence MS, Lichtenstein L, Stewart C, Koster J, Versteeg R, van Oudenaarden A, Saez-Rodriguez J, Vries RG, Getz G, Wessels L, Stratton MR, McDermott U, Meyerson M, Garnett MJ, Clevers H (2015) Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161:933–945. https://doi.org/10.1016/j.cell.2015.03.053
Vanhollebeke B, Stone OA, Bostaille N, Cho C, Zhou Y, Maquet E, Gauquier A, Cabochette P, Fukuhara S, Mochizuki N, Nathans J, Stainier DY (2015) Tip cell-specific requirement for an atypical Gpr124- and Reck-dependent Wnt/beta-catenin pathway during brain angiogenesis. eLife 4. https://doi.org/10.7554/eLife.06489
Voloshanenko O, Gmach P, Winter J, Kranz D, Boutros M (2017) Mapping of Wnt-frizzled interactions by multiplex CRISPR targeting of receptor gene families. FASEB J 31:4832–4844. https://doi.org/10.1096/fj.201700144R
Wallstabe L, Gottlich C, Nelke LC, Kuhnemundt J, Schwarz T, Nerreter T, Einsele H, Walles H, Dandekar G, Nietzer SL, Hudecek M (2019) ROR1-CAR T cells are effective against lung and breast cancer in advanced microphysiologic 3D tumor models. JCI insight 4. https://doi.org/10.1172/jci.insight.126345
Wang X, Reid Sutton V, Omar Peraza-Llanes J, Yu Z, Rosetta R, Kou YC, Eble TN, Patel A, Thaller C, Fang P, Van den Veyver IB (2007) Mutations in X-linked PORCN, a putative regulator of Wnt signaling, cause focal dermal hypoplasia. Nat Genet 39:836–838. https://doi.org/10.1038/ng2057
Weissenbock M, Latham R, Nishita M, Wolff LI, Ho HH, Minami Y, Hartmann C (2019) Genetic interactions between Ror2 and Wnt9a, Ror1 and Wnt9a and Ror2 and Ror1: phenotypic analysis of the limb skeleton and palate in compound mutants. Genes Cells 24:307–317. https://doi.org/10.1111/gtc.12676
Willert KH (2008) Isolation and application of bioactive Wnt proteins. Methods Mol Biol 468:17–29. https://doi.org/10.1007/978-1-59745-249-6_2
Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, Reya T, Yates JR 3rd, Nusse R (2003) Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature 423:448–452. https://doi.org/10.1038/nature01611
Yamada M, Udagawa J, Matsumoto A, Hashimoto R, Hatta T, Nishita M, Minami Y, Otani H (2010) Ror2 is required for midgut elongation during mouse development. Dev Dyn 239:941–953. https://doi.org/10.1002/dvdy.22212
You L, He B, Xu Z, Uematsu K, Mazieres J, Mikami I, Reguart N, Moody TW, Kitajewski J, McCormick F, Jablons DM (2004) Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Oncogene 23:6170–6174. https://doi.org/10.1038/sj.onc.1207844
Yu J, Chen L, Cui B, Widhopf GF 2nd, Shen Z, Wu R, Zhang L, Zhang S, Briggs SP, Kipps TJ (2016) Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation. J Clin Invest 126:585–598. https://doi.org/10.1172/JCI83535
Yu J, Yusoff PAM, Woutersen DTJ, Goh P, Harmston N, Smits R, Epstein DM, Virshup DM, Madan B (2020) The functional landscape of patient-derived RNF43 mutations predicts sensitivity to Wnt inhibition. Cancer Res 80:5619–5632. https://doi.org/10.1158/0008-5472.CAN-20-0957
Zebisch M, Jones EY (2015) Crystal structure of R-spondin 2 in complex with the ectodomains of its receptors LGR5 and ZNRF3. J Struct Biol 191:149–155. https://doi.org/10.1016/j.jsb.2015.05.008
Zhai L, Chaturvedi D, Cumberledge S (2004) Drosophila wnt-1 undergoes a hydrophobic modification and is targeted to lipid rafts, a process that requires porcupine. J Biol Chem 279:33220–33227. https://doi.org/10.1074/jbc.M403407200
Zhang X, Abreu JG, Yokota C, MacDonald BT, Singh S, Coburn KL, Cheong SM, Zhang MM, Ye QZ, Hang HC, Steen H, He X (2012) Tiki1 is required for head formation via Wnt cleavage-oxidation and inactivation. Cell 149:1565–1577. https://doi.org/10.1016/j.cell.2012.04.039
Zhang M, Haughey M, Wang NY, Blease K, Kapoun AM, Couto S, Belka I, Hoey T, Groza M, Hartke J, Bennett B, Cain J, Gurney A, Benish B, Castiglioni P, Drew C, Lachowicz J, Carayannopoulos L, Nathan SD, Distler J, Brenner DA, Hariharan K, Cho H, Xie W (2020a) Targeting the Wnt signaling pathway through R-spondin 3 identifies an anti-fibrosis treatment strategy for multiple organs. PLoS One 15:e0229445. https://doi.org/10.1371/journal.pone.0229445
Zhang Z, Broderick C, Nishimoto M, Yamaguchi T, Lee SJ, Zhang H, Chen H, Patel M, Ye J, Ponce A, Brady J, Baribault H, Li Y, Yeh WC (2020b) Tissue-targeted R-spondin mimetics for liver regeneration. Sci Rep 10:13951. https://doi.org/10.1038/s41598-020-70912-3
Zhou Y, Nathans J (2014) Gpr124 controls CNS angiogenesis and blood-brain barrier integrity by promoting ligand-specific canonical wnt signaling. Dev Cell 31:248–256. https://doi.org/10.1016/j.devcel.2014.08.018
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sonavane, P.R., Willert, K. (2021). Controlling Wnt Signaling Specificity and Implications for Targeting WNTs Pharmacologically. In: Schulte, G., Kozielewicz, P. (eds) Pharmacology of the WNT Signaling System. Handbook of Experimental Pharmacology, vol 269. Springer, Cham. https://doi.org/10.1007/164_2021_529
Download citation
DOI: https://doi.org/10.1007/164_2021_529
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-85498-0
Online ISBN: 978-3-030-85499-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)